Delivery Order SPE2DR25D2005-SPE2DR26FE6N4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,989.76 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used to treat inflammatory conditions. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, carries a firm fixed price and represents a non-competitive delivery order. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in treating inflammatory conditions. The contract was awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $7,810.81 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. The contract, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take...
- The Defense Logistics Agency awarded a delivery order valued at $5,394.96 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of inflammatory conditions. This non-set-aside, firm fixed price delivery order was competitively awarded on October 20, 2025, with an ultimate completion date of October 21, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $11,606.14 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune diseases. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency issued a delivery order worth $4,145.88 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-competitive award under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $4,531.80 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $15,809.98 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement processes. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,662.84 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for treating inflammatory conditions. This competitively awarded, firm fixed-price delivery order was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,166.56 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competed delivery order under AmerisourceBergen's existing DLA contract vehicle. The place of performance is listed as the company's corporate office in...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6N4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,775.88 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed price, non-competitive delivery order was issued on November 7, 2025, with a completion deadline of November 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical procurement supporting military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order represents a routine pharmaceutical fulfillment transaction within the company's extensive federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 11/7/25 |